Insider · CIK 0001701247

Collins Helen Louise

Reports to the SEC for 4 companies · BURLINGAME, CA

sec.gov

Transactions

Companies

Filings

CIK

0001701247

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	106,268
2026-09-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,844 sh	$50.71	−$93.5K	25,240
2026-09-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−240 sh	$51.48	−$12.4K	25,000
2026-09-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,916 sh	$50.03	−$146K	27,084
2026-09-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-08-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-08-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−3,900 sh	$58.37	−$228K	26,100
2026-08-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	111,268
2026-08-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,100 sh	$59.35	−$65.3K	25,000
2026-07-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	116,268
2026-07-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−459 sh	$51.55	−$23.7K	29,310
2026-07-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−63 sh	$53.92	−$3,397.01	25,000
2026-07-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,063 sh	$52.39	−$108K	27,247
2026-07-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-07-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,184 sh	$53.42	−$117K	25,063
2026-07-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−231 sh	$50.05	−$11.6K	29,769
2026-06-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,268 sh	$42.83	−$54.3K	28,732
2026-06-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,599 sh	$43.87	−$114K	26,133
2026-06-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,133 sh	$44.74	−$50.7K	25,000
2026-06-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	121,268
2026-06-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-05-18	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-05-18	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−3,475 sh	$39.53	−$137K	26,525
2026-05-18	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,302 sh	$40.25	−$52.4K	25,223
2026-05-18	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−223 sh	$41.21	−$9,188.76	25,000
2026-05-18	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	126,268
2026-04-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	131,268
2026-04-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-04-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−140 sh	$45.81	−$6,413.498	29,860
2026-04-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,419 sh	$47.39	−$115K	27,441
2026-04-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,441 sh	$48.06	−$117K	25,000
2026-03-25	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+40K sh	$2.48	+$99.2K	65,000
2026-03-25	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−40K sh	$35.10	−$1.4M	25,000
2026-03-25	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−40K sh	—	—	136,268
2026-03-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	$2.48	+$12.4K	30,000
2026-03-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	176,268
2026-03-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−5,000 sh	$27.76	−$139K	25,000
2026-03-10	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+10.1K sh	$2.48	+$25.1K	35,129
2026-03-10	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−10.1K sh	$30.19	−$306K	25,000
2026-03-10	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−10.1K sh	—	—	181,268
2026-03-09	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−29.9K sh	—	—	191,397
2026-03-09	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+29.9K sh	$2.48	+$74.1K	54,871
2026-03-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−29.9K sh	$30.02	−$897K	25,000
2026-02-17	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+45K sh	$2.48	+$112K	70,000
2026-02-17	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−45K sh	$26.17	−$1.18M	25,000
2026-02-17	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−45K sh	—	—	221,268
2026-02-12	ELVNEnliven Therapeutics, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+25K sh	—	—	25,000
2026-02-12	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER	AAward	+150K sh	—	—	150,000
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500

Recent filings

Accepted (ET)
Sep 214
Collins Helen Louise0001701247-26-000013
SEC(opens sec.gov)
Aug 194
Collins Helen Louise0001701247-26-000012
SEC(opens sec.gov)
Jul 214
Collins Helen Louise0001701247-26-000011
SEC(opens sec.gov)
Jun 224
Collins Helen Louise0001701247-26-000010
SEC(opens sec.gov)

Companies

Address

C/O ENLIVEN THERAPEUTICS, INC. 205 PARK ROAD

BURLINGAME, CA, 94010